- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01545869
Efficacy and Safety of Fractional Carbon Dioxide Laser for Treatment of Facial Freckles.
Efficacy and Safety of Fractional Carbon Dioxide Laser for Treatment of Facial Freckles
Freckles are clusters of melanin in the superficial epidermis. They affect mostly face and sun exposed areas, and appear as flat brown or red macules that fade in winter, usually in a fair complexion patient, but may be present in other skin types.
The gold standard in the industry for non-surgical facial rejuvenation, removal of wrinkles, pigmentation, and general sun damage has been the carbon dioxide (CO2) laser since the mid 1990s. The traditional CO2 laser was very effective, however it fell out of favor because it required general anesthesia. It also had a prolonged recovery time. Over the last several years, advances in technology known as fractional resurfacing has made the CO2 laser popular again: Fractional CO2 laser treatment is one of the newest laser rejuvenation technology. It proved successful in treatment of melasma, one of the pigmented dermatoses. To the best of our knowledge, based on a thorough search of literature, no clinical studies assessing fractional CO2 laser in treatment of freckles could be retrieved.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Cairo, Egypt
- Dermatology department - faculty of medicine- Cairo University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- -Patients affected with facial freckles.
- Age: 10 years or more
Exclusion Criteria:
- Patients younger than 10 years old.
- Patients aged 10-21 years who can not provide a written consent of parents or legal guardian.
- Patients with known tendency to keloid or hypertrophic scar formation.
- Patients receiving treatment with systemic retinoids or having stopped their course since less than six months duration.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Fractional carbon dioxide laser
|
SmartXide fractional carbon dioxide laser (DEKA, Florence, Italy).
Parameters adjusted for: Power 20 watts, spacing 200 µsec, dwell time 300 µm, stacks 1.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
treatment success
Time Frame: One month
|
reduction of freckles number and color density more than 50% in comparison to pre-treatment digital photos
|
One month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Treatment safety
Time Frame: three months
|
Absence of irreversible changes in color and texture of the facial skin, that can cause patient dissatisfaction
|
three months
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Bakr M Elzawahry, MD, Cairo University
- Principal Investigator: Aya Fahim, MBBCh, Cairo University
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Fractional CO2 in freckles
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Freckles
-
Kasr El Aini HospitalUnknownTherapeutic EfficacyEgypt
Clinical Trials on Fractional carbon dioxide laser
-
Qilu Hospital of Shandong UniversityRecruitingStress Urinary IncontinenceChina
-
Cairo UniversityCompleted
-
Laserklinik KarlsruheCompleted
-
Laserklinik KarlsruheCompleted
-
Moy-Fincher Medical GroupUnknown
-
Moy-Fincher Medical GroupCompleted
-
Massachusetts General HospitalRecruitingBurn Scar | Hypertrophic ScarUnited States
-
Assiut UniversityNot yet recruitingAcne Scars - AtrophicEgypt
-
Seoul National University HospitalCompleted
-
Mayo ClinicNational Cancer Institute (NCI)WithdrawnAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic... and other conditions